International CEO praises Danish testing efforts for "thinking more strategically and long-term than other places"

The Covid-19 pandemic has opened the authorities' eyes to the value of early diagnostics, says Roche CEO, who highlights Denmark and the UK as places where the authorities are working proactively.

Photo: Roche/PR

It might sound strange, but the Covid-19 pandemic could potentially help save people from dying of cancer and hepatitis.

Thomas Shinecker, CEO of Roche Diagnostics, already sees signs that healthcare authorities around the world will invest more in early diagnostics for a number of diseases following the Covid-19 pandemic.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs